# Alabama Medical Cannabis Sales Spring 2026 Launch Update > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/alabama-medical-cannabis-sales-spring-2026/ > **Published:** 2026-05-02T13:44:41-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:56:26-04:00 > **Clinical Summary:** Explore the Alabama medical cannabis sales spring 2026 launch and its clinical relevance for healthcare professionals and patients. --- CED Digest**May 02, 2026. 4 items curated for clinical relevance. ### Above Threshold [Alabama Medical Cannabis Sales Gear for Spring 2026 Launch](https://www.cannabisbusinesstimes.com/us-states/alabama/news/15819031/alabama-medical-cannabis-sales-gear-for-spring-2026-launch) This article previews the anticipated launch of [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) sales in Alabama during spring 2026, signifying an important expansion for healthcare professionals specializing in cannabis who can now serve more patients in that region. [Read more →](https://www.cannabisbusinesstimes.com/us-states/alabama/news/15819031/alabama-medical-cannabis-sales-gear-for-spring-2026-launch) [Cannabis compounds CBD and CBG may help reverse fatty liver disease, study finds](https://www.sciencedaily.com/releases/2026/03/260306145616.htm) This article highlights a new study indicating that cannabinoids CBD and CBG from cannabis may potentially reverse [fatty liver disease](https://cedclinic.com/cannabinoid-receptor-type-1-antagonist-obesity-steatohepatitis/), which could be significant for cannabis clinicians as these compounds might offer potential therapeutic options for this prevalent condition. [Read more →](https://www.sciencedaily.com/releases/2026/03/260306145616.htm) [From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry’s …](https://www.theglobeandmail.com/investing/markets/markets-news/ACCESS Newswire/612739/from-billion-dollar-hemp-drinks-to-fda-cease-and-desist-letters-the-cannabis-industry-s-reckoning-is-coming/) This article discusses the evolution of the [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/), focusing on the rise of billion-dollar hemp drinks and regulatory challenges, which is significant for cannabis clinicians as understanding industry trends and regulatory changes can inform evidence-based [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) practices. [Read more →](https://www.theglobeandmail.com/investing/markets/markets-news/ACCESS Newswire/612739/from-billion-dollar-hemp-drinks-to-fda-cease-and-desist-letters-the-cannabis-industry-s-reckoning-is-coming/) [New Cannabis Group Will Help Ground Policy In Science And Patient Experience As …](https://www.marijuanamoment.net/new-cannabis-group-will-help-ground-policy-in-science-and-patient-experience-as-trumps-rescheduling-move-advances-op-ed/) This article introduces a new cannabis group focused on basing policy decisions on scientific research and patient experiences, which is significant for cannabis clinicians as it emphasizes evidence-based practices, improving the quality of care provided to patients. [Read more →](https://www.marijuanamoment.net/new-cannabis-group-will-help-ground-policy-in-science-and-patient-experience-as-trumps-rescheduling-move-advances-op-ed/) Digest-Level Clinical Commentary Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20CED%20Digest%3A%204%20Items%20%E2%80%94%20May%2002%2C%202026%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fced-digest-4-items-may-02-2026%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fced-digest-4-items-may-02-2026%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20CED%20Digest%3A%204%20Items%20%E2%80%94%20May%2002%2C%202026%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fced-digest-4-items-may-02-2026%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [CED Digest: 23 Items — April 25, 2026](https://cedclinic.com/cannabis-clinical-updates-april-25-2026/) - [Alabama Medical Cannabis** Sales Gear for Spring 2026 Launch](https://cedclinic.com/alabama-medical-cannabis-program-moves-forward-2026/) - [CED Digest: 35 Items — April 09, 2026](https://cedclinic.com/alabama-medical-cannabis-sales-april-2026-digest/) Further Reading Cannabis Policy WireCED Regulatory Digest, Since Last Digest, 1 items Research Digest[Research Digest: 20 Recent Studies – May 02, 2026](https://cedclinic.com/cannabinoid-based-interventions-autism-safety-effectiveness-2026/) CED Clinic Blog[What Federal Cannabis Rescheduling Means for Care](https://cedclinic.com/cannabis-schedule-iii-rescheduling-explained/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [CED Digest: 23 Items — April 25, 2026](https://cedclinic.com/cannabis-clinical-updates-april-25-2026/) Review recent clinical updates and policy developments in cannabis from the April 25, 2026 digest. [Read More](https://cedclinic.com/cannabis-clinical-updates-april-25-2026/) [CED Digest: 35 Items — April 02, 2026](https://cedclinic.com/cannabis-cannabinoids-cbd-and-cbg-therapeutic-effects/) Explore therapeutic effects of cannabis cannabinoids CBD and CBG relevant to clinical practice. [Explore Insights](https://cedclinic.com/cannabis-cannabinoids-cbd-and-cbg-therapeutic-effects/) [CED Digest: 405 Items — March 12, 2026](https://cedclinic.com/alabama-medical-cannabis-sales-2026-spring-launch/) Comprehensive cannabis clinical updates and research summaries from March 12, 2026. [Discover More](https://cedclinic.com/alabama-medical-cannabis-sales-2026-spring-launch/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).